This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Sysmex Corporation. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations of Yuri Takagi in Blood Analysis
Introduction
Yuri Takagi is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medical technology, particularly in blood analysis. His innovative approach has led to the development of a unique blood analyzer that enhances the understanding of lymphocyte populations.
Latest Patents
Yuri Takagi holds a patent for a blood analyzer and blood analyzing method. This invention provides a means to obtain information regarding B lymphocytes and T lymphocytes without the need for a fluorescence-labeled antibody. The blood analyzer includes a blood specimen supplying portion, a sample preparation portion that prepares a measurement sample by mixing a blood specimen with a hemolyzing agent and a fluorescent dye that stains nucleic acid. It also features a light source, a first detector for fluorescence detection, a second detector for scattered light detection, and an information processing portion that classifies lymphocytes based on fluorescence and scattered light intensity. This innovative method allows for the efficient classification of lymphocytes and the acquisition of valuable information regarding B-lymphocytes and T-lymphocytes.
Career Highlights
Yuri Takagi is associated with Sysmex Corporation, a company renowned for its advancements in medical diagnostics. His work has contributed to the company's reputation as a leader in blood analysis technology. With a focus on innovation, Takagi continues to push the boundaries of what is possible in the field.
Collaborations
Some of his notable coworkers include Mari Kono and Shoichiro Asada. Their collaborative efforts have further enhanced the development of innovative solutions in blood analysis.
Conclusion
Yuri Takagi's contributions to blood analysis through his patented inventions demonstrate the importance of innovation in medical technology. His work not only advances the field but also provides critical insights into lymphocyte populations, ultimately benefiting healthcare practices.